Member Info for Shukan

added a few while no one is looking

EB - AVOID

Countries are testing - using existing methods -the prime objective is containment

nothing to see here

NO ATTACKS THE human respiratory system - lungs fill with fluid you drown

Indeed you are correct- we will see how it plays out

Peter purchased shares in the placing .

In a nutshell the existing product portfolio will enhanced , what I can post is from the 15th January from Peter Redmond
“ I hope you saw today's announcement which is very significant progress. Vladik has been working on it for some time but we could not announce till the results of the lab tests were known and positive. It means we are on the way to a direct cure for the most common and for the majority of sufferers deadly forms of leukaemia - which was not even on the agenda when the company came to market. I hope people understand that this is important news. And there is more in pipeline. I am happy for you to pass this on and I am happy to talk to you if you wanted to call.”
As OnTarget has quite rightly pointed out we have the Global Pharma in the background - the CAR-T developments linked into this I would suggest , I will need confirm this though , I do know there was a meeting of minds , also related to the CDX- anti-bodies having to meet clinical grade .

For those that understand CAR-T treatment and adverse effects on the patient that have to be countered by steroids
This is significant, I will continue to add as there is a lot of news in the pipe line

I’ve added again to my holding -
“Following the successful completion of these tests, Hemogenyx is undertaking further engineering of HEMO-CAR to enhance the activity of the technology. The Company is introducing and testing a safety switch within the HEMO-CAR technology that is designed to control the level of activity of HEMO-CAR-T cells. The aim of this safety switch is to turn HEMO-CAR-T cells into a "tunable and controllable drug". The purpose of these efforts is to dramatically improve the safety and potential versatility of HEMO-CAR-T cells for the treatment of AML and/or conditioning of bone marrow transplants, as well as a number of additional potential indications.”

Given up on this rubbish -74% down on a £7K buy back in the day - another Australian Ponzi Scheme duster

BUY AND HOLD

https://www.investegate.co.uk/hemogenyx-pharma-plc--hemo-/rns/hemo-car-t-cells-effective-against-aml-in-vivo/202002200700075325D/

in full
https://ir.orgenesis.com/press-releases/detail/144

Refreshed new look - https://hemogenyx.com/

MM sold this down to 1.6p - no rhyme or reason , any decent trade volume it goes NT

We see a group of five patients who have all been successful recipients of the CAR T-cell therapy, who are now between nine and 25 months in remission who have the knowledge and research gained on Graham's and Mahmoud's cases to thank for hopefully seeing off their cancer for good

War in the Blood was broadcast on BBC Two on July 7th and is available to watch on BBC iPlayer now.

https://www.hitc.com/en-gb/2019/07/08/war-in-the-blood-graham-threader-mahmoud-kayiisi-cancer/

2020 will be a good year - PR ramping up- collaboration deals - CDX-antibody updates, Hemogenyx CAR-t not targeting the usual CD19 protein suspect on ALL cancer cell expect an update on this one exciting times ahead

https://www.theguardian.com/tv-and-radio/2019/jul/07/war-in-the-blood-review-love-hope-and-the-search-for-a-cancer-cure